
New Technique Grows Realistic Bone in a Dish
It’s one of the most challenging organs to re-create
| May | JUN | Jul |
| 06 | ||
| 2020 | 2021 | 2022 |


It’s one of the most challenging organs to re-create

A pediatric infectious disease expert answers questions about whether the vaccine is safe and why children need it

Preliminary results from a trial of more than 600 people are the first to show the benefits of combining different vaccines

People older than 80 who waited 11 to 12 weeks for their second jab had higher peak antibody levels than did those who waited only three weeks

Pfizer-BioNTech vaccine approval is younger teens’ shot at freedom

Hopes are high for a class of drug that could treat neurodegenerative conditions—but a recent clinical trial has brought the field up short

The illegal substance—paired with intensive therapy and hard work—dramatically improves PTSD symptoms

Hopes were high for drugs designed to lower levels of a mutant protein, but development has stalled

The development from the Biden administration draws cheers from public health researchers and ire from drugmakers

Clear messaging and transparency are vital, say some experts on risk assessment and decision-making

Next-generation COVID-19 vaccines will not only tackle different versions of the virus but will provide solutions across the world at a fraction of the cost

The new DNA-based test predicts transplant rejection

Preliminary results suggest the vaccine is up to 77 percent effective in young children, but researchers await larger studies

It was lysozyme, an enzyme that attacks the cell walls of bacteria—and just as with the celebrated antibiotic, he found it through pure serendipity

Infectious disease physician-scientist Wilbur Chen discusses the rare cases of blood clots linked to the immunization

For the first time, a randomized controlled trial shows the psychedelic offers potent, if short-term, relief in comparison with an SSRI

An infectious disease doctor answers questions about the CDC’s and FDA’s decision to pause the vaccine’s use over a possible link with blood clots

Researchers are searching for possible links between unusual clotting and the Oxford-AstraZeneca coronavirus vaccine

Pulmonary fibrosis is diagnosed in about 50,000 new patients annually, and as many as 40,000 Americans die from it each year

The pandemic has spotlighted ways to make clinical trials easier on patients and better for science, a heart drug researcher says
You have free articles left.

Support our award-winning coverage of advances in science & technology.
Already a subscriber? Sign in.
